vs
Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and SCANSOURCE, INC. (SCSC). Click either name above to swap in a different company.
Astrana Health, Inc. is the larger business by last-quarter revenue ($950.5M vs $766.5M, roughly 1.2× SCANSOURCE, INC.). SCANSOURCE, INC. runs the higher net margin — 2.2% vs 0.7%, a 1.5% gap on every dollar of revenue. On growth, Astrana Health, Inc. posted the faster year-over-year revenue change (42.9% vs 2.5%). SCANSOURCE, INC. produced more free cash flow last quarter ($28.9M vs $-6.0M). Over the past eight quarters, Astrana Health, Inc.'s revenue compounded faster (53.3% CAGR vs 0.9%).
Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.
ScanSource, Inc. is a leading global specialty technology distributor offering a broad portfolio of solutions including point-of-sale systems, barcode scanning tools, cybersecurity products, cloud services and communication solutions. It primarily serves value-added resellers, managed service providers and enterprise clients across North America, Latin America and Europe, covering retail, healthcare, industrial and public sector core segments.
ASTH vs SCSC — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $950.5M | $766.5M |
| Net Profit | $6.6M | $16.5M |
| Gross Margin | — | 13.4% |
| Operating Margin | 1.9% | 2.3% |
| Net Margin | 0.7% | 2.2% |
| Revenue YoY | 42.9% | 2.5% |
| Net Profit YoY | 184.4% | -3.3% |
| EPS (diluted) | $0.12 | $0.75 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $950.5M | $766.5M | ||
| Q3 25 | $956.0M | $739.6M | ||
| Q2 25 | $654.8M | $812.9M | ||
| Q1 25 | $620.4M | $704.8M | ||
| Q4 24 | $665.2M | $747.5M | ||
| Q3 24 | $478.7M | $775.6M | ||
| Q2 24 | $486.3M | $746.1M | ||
| Q1 24 | $404.4M | $752.6M |
| Q4 25 | $6.6M | $16.5M | ||
| Q3 25 | $373.0K | $19.9M | ||
| Q2 25 | $9.4M | $20.1M | ||
| Q1 25 | $6.7M | $17.4M | ||
| Q4 24 | $-7.8M | $17.1M | ||
| Q3 24 | $16.1M | $17.0M | ||
| Q2 24 | $19.2M | $16.1M | ||
| Q1 24 | $14.8M | $12.8M |
| Q4 25 | — | 13.4% | ||
| Q3 25 | — | 14.5% | ||
| Q2 25 | — | 12.9% | ||
| Q1 25 | — | 14.2% | ||
| Q4 24 | — | 13.6% | ||
| Q3 24 | — | 13.1% | ||
| Q2 24 | — | 13.0% | ||
| Q1 24 | — | 12.6% |
| Q4 25 | 1.9% | 2.3% | ||
| Q3 25 | 2.0% | 3.5% | ||
| Q2 25 | 3.1% | 3.3% | ||
| Q1 25 | 3.3% | 3.2% | ||
| Q4 24 | 0.1% | 2.5% | ||
| Q3 24 | 5.9% | 2.3% | ||
| Q2 24 | 6.2% | 2.9% | ||
| Q1 24 | 7.5% | 2.3% |
| Q4 25 | 0.7% | 2.2% | ||
| Q3 25 | 0.0% | 2.7% | ||
| Q2 25 | 1.4% | 2.5% | ||
| Q1 25 | 1.1% | 2.5% | ||
| Q4 24 | -1.2% | 2.3% | ||
| Q3 24 | 3.4% | 2.2% | ||
| Q2 24 | 3.9% | 2.2% | ||
| Q1 24 | 3.7% | 1.7% |
| Q4 25 | $0.12 | $0.75 | ||
| Q3 25 | $0.01 | $0.89 | ||
| Q2 25 | $0.19 | $0.87 | ||
| Q1 25 | $0.14 | $0.74 | ||
| Q4 24 | $-0.14 | $0.70 | ||
| Q3 24 | $0.33 | $0.69 | ||
| Q2 24 | $0.40 | $0.66 | ||
| Q1 24 | $0.31 | $0.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $429.5M | $83.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $779.3M | $910.9M |
| Total Assets | $2.2B | $1.7B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $429.5M | $83.5M | ||
| Q3 25 | $463.4M | $124.9M | ||
| Q2 25 | $342.1M | $126.2M | ||
| Q1 25 | $260.9M | $146.3M | ||
| Q4 24 | $290.8M | $110.5M | ||
| Q3 24 | $350.3M | $145.0M | ||
| Q2 24 | $327.7M | $185.5M | ||
| Q1 24 | $337.3M | $159.1M |
| Q4 25 | $779.3M | $910.9M | ||
| Q3 25 | $775.5M | $914.0M | ||
| Q2 25 | $765.5M | $906.4M | ||
| Q1 25 | $745.4M | $901.7M | ||
| Q4 24 | $712.7M | $900.7M | ||
| Q3 24 | $704.6M | $920.9M | ||
| Q2 24 | $678.9M | $924.3M | ||
| Q1 24 | $653.5M | $944.1M |
| Q4 25 | $2.2B | $1.7B | ||
| Q3 25 | $2.2B | $1.7B | ||
| Q2 25 | $1.4B | $1.8B | ||
| Q1 25 | $1.3B | $1.7B | ||
| Q4 24 | $1.4B | $1.7B | ||
| Q3 24 | $1.3B | $1.8B | ||
| Q2 24 | $1.3B | $1.8B | ||
| Q1 24 | $1.2B | $1.8B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.9M | $30.8M |
| Free Cash FlowOCF − Capex | $-6.0M | $28.9M |
| FCF MarginFCF / Revenue | -0.6% | 3.8% |
| Capex IntensityCapex / Revenue | 0.3% | 0.3% |
| Cash ConversionOCF / Net Profit | -0.44× | 1.87× |
| TTM Free Cash FlowTrailing 4 quarters | $104.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.9M | $30.8M | ||
| Q3 25 | $10.0M | $23.2M | ||
| Q2 25 | $90.9M | — | ||
| Q1 25 | $16.6M | $66.1M | ||
| Q4 24 | $-10.9M | $-6.2M | ||
| Q3 24 | $34.0M | $44.8M | ||
| Q2 24 | $23.2M | — | ||
| Q1 24 | $6.0M | $160.2M |
| Q4 25 | $-6.0M | $28.9M | ||
| Q3 25 | $7.4M | $20.8M | ||
| Q2 25 | $89.5M | — | ||
| Q1 25 | $13.6M | $64.6M | ||
| Q4 24 | $-13.5M | $-8.2M | ||
| Q3 24 | $31.7M | $42.5M | ||
| Q2 24 | $20.4M | — | ||
| Q1 24 | $5.6M | $157.7M |
| Q4 25 | -0.6% | 3.8% | ||
| Q3 25 | 0.8% | 2.8% | ||
| Q2 25 | 13.7% | — | ||
| Q1 25 | 2.2% | 9.2% | ||
| Q4 24 | -2.0% | -1.1% | ||
| Q3 24 | 6.6% | 5.5% | ||
| Q2 24 | 4.2% | — | ||
| Q1 24 | 1.4% | 21.0% |
| Q4 25 | 0.3% | 0.3% | ||
| Q3 25 | 0.3% | 0.3% | ||
| Q2 25 | 0.2% | 0.3% | ||
| Q1 25 | 0.5% | 0.2% | ||
| Q4 24 | 0.4% | 0.3% | ||
| Q3 24 | 0.5% | 0.3% | ||
| Q2 24 | 0.6% | 0.2% | ||
| Q1 24 | 0.1% | 0.3% |
| Q4 25 | -0.44× | 1.87× | ||
| Q3 25 | 26.69× | 1.17× | ||
| Q2 25 | 9.65× | — | ||
| Q1 25 | 2.48× | 3.79× | ||
| Q4 24 | — | -0.36× | ||
| Q3 24 | 2.11× | 2.64× | ||
| Q2 24 | 1.21× | — | ||
| Q1 24 | 0.40× | 12.51× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
SCSC
| Products And Services | $723.4M | 94% |
| Intelisys Advisory | $25.0M | 3% |
| Recurring Revenue | $18.2M | 2% |
